close

​​

Search Re​sults​​

​​
Sort by Recent Relevant​

Already on an IPO high, biotech looks for a sequel to the JOBS Act

News

5/2/2014 - Fenwick corporate partner Matthew Rossiter was quoted by the San Francisco Business Times about the impact of the federal Jumpstart Our Business Startups (JOBS) Act on initial public offerings in the biotech industry.

Federal Circuit Rehearing Could Redefine Patent Law

News

10/10/2012 - Robert Sachs is quoted in an article on patent law.

No Glitz, No Glamour

News

8/29/2012 - Fenwick & West was featured and chief information officer, Matt Kesner, was quoted in an article from The American Lawyer titled “No Glitz, No Glamour.”

Fenwick Helps Lexar Through Picture-Perfect Stock Offering

News

12/19/2002 - Attorneys in the Palo Alto office of Fenwick & West represented Fremont-based Lexar Media Inc. in a $25.8 million public offering of 4.3 million shares.

Gilead’s Hypertension Drug Darusentan Will Likely Receive Patent Extension, Attorneys Say

News

4/6/2009 - Narinder Banait was recently quoted in the Pharmawire article, 'Gilead's Hypertension Drug Darusentan Will Likely Receive Patent Extension, Attorneys Say

Licensing and IP Issues for Mobile and Social Game Developers

News

6/13/2013 - Copyright group chair Jennifer Stanley and litigator Jennifer Kelly were quoted by IP Strategy on the intellectual property issues that most often arise for game developers.

Fenwick Representation of Cepheid in $4B Acquisition by Danaher Covered Nationally

News

9/6/2016 - Fenwick’s representation of Cepheid, a leading molecular diagnostics company, in its $4B acquisition by Danaher Corporation was covered by Fortune, Reuters, CNBC, Law360 and The American Lawyer (subscriptions may be required).

Patenting Nature and Seattle Biotech

News

4/29/2010 - Andrew T. Serafini, Ph.D., and IP partner in the Life Sciences Group at Fenwick & West LLP, was recently featured on the National Public Radio KUOW segment

Federal Circuit Tightens Standard for AIA Review

News

11/21/2016 - Fenwick litigation partner Darren Donnelly discusses the Federal Circuit's move to tighten standards for AIA review.

Life Sciences Public Offerings Alive in 2015

News

2/5/2015 - Fenwick & West securities co-chair Rob Freedman was featured in a Law360 article about 2015 shaping up to be an even stronger year than 2014 for life sciences companies’ public offerings and eager investors buying in.

11-20 of 24 results

Already on an IPO high, biotech looks for a sequel to the JOBS Act

News

5/2/2014 - Fenwick corporate partner Matthew Rossiter was quoted by the San Francisco Business Times about the impact of the federal Jumpstart Our Business Startups (JOBS) Act on initial public offerings in the biotech industry.

Licensing and IP Issues for Mobile and Social Game Developers

News

6/13/2013 - Copyright group chair Jennifer Stanley and litigator Jennifer Kelly were quoted by IP Strategy on the intellectual property issues that most often arise for game developers.

Fenwick Wins Two M&A Deal of the Year Awards from Global M&A Network

Press Release

10/24/2012 - Fenwick & West was honored by Global M&A Network for 2012 Deal of the Year in two categories at the organization’s annual M&A Atlas Awards gala at the New York Marriot Marquis on October 24 from among the more than 600 submissions received.

Federal Circuit Rehearing Could Redefine Patent Law

News

10/10/2012 - Robert Sachs is quoted in an article on patent law.

Dow Chemical Loses U.S. Court Test of R&D Tax Credits

News

9/7/2012 - Fenwick partner Michael Solomon was quoted in a Reuters article titled “Dow Chemical loses U.S. court test of R&D tax credits.”

No Glitz, No Glamour

News

8/29/2012 - Fenwick & West was featured and chief information officer, Matt Kesner, was quoted in an article from The American Lawyer titled “No Glitz, No Glamour.”

Doctors Fear Copyright Crackdown on Medical Procedures

News

1/4/2012 - Mitchell Zimmerman, Chair of the Copyright Group at Fenwick & West, was recently quoted in the San Francisco Examiner article

Prometheus – Unbound or Not

News

11/3/2011 - Michael Shuster, co-chair of the Life Sciences Group with Fenwick & West, was recently quoted in the Drug Discovery News article

Why Flash is the Future of Storage in Data Centers

News

8/23/2011 - Matt Kesner, Chief Information Officer of Fenwick & West, was recently quoted in The New York Times article “Why Flash is the Future of Storage in Data Centers.”

Fenwick & West Client CardioDx's Blood Test Named As One of TIME Magazine's Top Ten Medical Breakthroughs of 2010

Press Release

12/27/2010 - TIME Magazine named CardioDx's blood-based gene expression test, Corus CAD, one of the Top Ten medical breakthroughs of 2010. The Corus CAD test also won a Technology Innovation Award from The Wall Street Journal this year.